ClinicalTrials.govpublic full text
Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics
pulmonary disease, chronic obstructive, first time in human, stable asthmatics, gsk3923868, inhalation powder, phosphatidylinositol 4-kinase beta, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876051
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.